Results of a phase 1B study of recombinant human APO2L/trail with rituximab in patients with relapsed, low-grade NHLM. Fanale,H. Burris, L. Yee, J. Lucas, K. Dimick, M. Goldwasser, W. Novotny,G. BrayANNALS OF ONCOLOGY(2008)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要